We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA is planning to revise its proposed study of effectiveness information in direct-to-consumer (DTC) ads for prescription drugs based on comments
it received to a previous proposal.